Here’s the latest on what the Trump presidency means for health, hospitals, drug companies, and medical research.
Friday, March 31
A generic drug downturn
Imports of generic drugs to the US fell 22 percent in the three months after the US election, compared with the three months before, notes the PharmaLetter. It’s a tricky intersection of policy: On the one hand, Trump’s election inspired hope to those who want to boost drug imports, but he’s also been highly critical of overseas manufacturing. Analysts blamed the downturn on wider health care uncertainty related to Trump’s promises of Obamacare repeal.
